Osteoporosis: all 1,675 studies

Page 15 of 17. Open to participants first (211), then studies with results posted, then the rest; newest registration first within each.

• The Effect of Vitamin K2 on Bone TurnoverCompletedNCT00548509Phase 4
• SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.CompletedNCT00545480Phase 4
• Effects of Hesperidin on Bone Biomarkers in Postmenopausal WomenCompletedNCT00545116Phase 2
• ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.CompletedNCT00545090Phase 4
• ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a WeekTerminatedNCT00544180Phase 4
• PTH Comparison in Post Menopausal WomenCompletedNCT00543218Phase 3
• A Study of the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00543023Phase 3
• Comparison Medications in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00542984Phase 3
• A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy WomenCompletedNCT00540878Phase 1
• Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate CancerCompletedNCT00536653Not applicable
• Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With OsteoporosisCompletedNCT00535860Phase 2
• Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)CompletedNCT00533650Phase 2
• Bone Marker Changes With Teriparatide/Postmenopausal OsteoporosisCompletedNCT00532545Phase 4
• Long Term Effects of Raloxifene Treatment on Bone QualityCompletedNCT00532428Phase 4
• Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or OsteoporosisCompletedNCT00532337Phase 2
• Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or PlaceboCompletedNCT00532246Phase 4
• Study of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00532207Phase 3
• A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in WomenCompletedNCT00532077Phase 1
• Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter SyndromeCompletedNCT00523835
• Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate CancerCompletedNCT00520052Not applicable
• Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468)CompletedNCT00519857Phase 3
• PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)CompletedNCT00515593
• Strategies to Treat Osteoporosis Following a Fragility FractureCompletedNCT00512499Not applicable
• Osteoporosis Coordinator for Low Volume Community HospitalsStatus unknownNCT00511693Not applicable
• A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy PeopleCompletedNCT00508534Phase 1
• Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in OsteoporosisCompletedNCT00500409Phase 3
• A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal WomenCompletedNCT00499928Phase 1
• Quantitative Diffusion and Fat Imaging of the SpineCompletedNCT00498277
• Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsStatus unknownNCT00497458Phase 2
• BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.CompletedNCT00493623Phase 3
• A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.No longer availableNCT00493532
• High Dosage Vitamin D and OsteoporosisCompletedNCT00491920Phase 4
• Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal WomenCompletedNCT00481169Phase 3
• A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)CompletedNCT00480766Phase 3
• Vitamin D Supplementation in Older WomenCompletedNCT00472823Not applicable
• The Effect of Weight Loss on Bone in MenCompletedNCT00472745Not applicable
• Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects.CompletedNCT00468689Phase 1
• FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) StudyCompletedNCT00465387Not applicable
• The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About OsteoporosisCompletedNCT00464412Phase 1
• Evaluation of the Impact of a Case-finding Strategy for Vertebral FracturesCompletedNCT00463905Not applicable
• Study of Male Osteoporosis and AgingStatus unknownNCT00463411
• The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone LossCompletedNCT00460057Phase 4
• Risedronate Sodium in Post Menopausal OsteoporosisCompletedNCT00453492Phase 4
• The Genetic and Life Style Determinants of Bone Mass of Young Greek MalesCompletedNCT00449215
• Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary OsteoporosisCompletedNCT00447915Phase 3
• The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral DensityTerminatedNCT00446589Phase 4
• Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal WomenCompletedNCT00443716Not applicable
• Falls Prevention in OsteoporosisCompletedNCT00432692Not applicable
• Provincial Roll-Out Bone Health StrategyWithdrawnNCT00431002Not applicable
• The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After MenopauseCompletedNCT00420940Phase 3
• Systematic Prevention of Further Fractures in Patients With Hip Fractures and Osteoporosis.Status unknownNCT00414830
• The Importance of Patient Education - A Randomised Controlled TrialCompletedNCT00414154Early Phase 1
• Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal WomenCompletedNCT00411125Phase 1
• A Dose-response Study With Strontium Malonate in Postmenopausal WomenCompletedNCT00409032Phase 2
• Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone DisordersStatus unknownNCT00403598
• Risedronate in the Prevention of Osteoporosis in Postmenopausal WomenCompletedNCT00402441Phase 4
• Upper GI Handling of Branded vs. Generic AlendronateCompletedNCT00400530Phase 3
• FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)CompletedNCT00398931Phase 3
• A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)CompletedNCT00398606Phase 3
• Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal WomenCompletedNCT00395395Phase 1
• Fosamax for Childhood Cancer SurvivorsStatus unknownNCT00391404Phase 3
• A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)CompletedNCT00389740Phase 3
• Addressing Vertebral Osteoporosis Incidentally Detected to Prevent Future FracturesCompletedNCT00388908Not applicable
• A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.CompletedNCT00388596Phase 1
• Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian WomenCompletedNCT00384072Phase 3
• Study Comparing Arzoxifene With Raloxifene in Women After Menopause With OsteoporosisCompletedNCT00383422Phase 3
• Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.CompletedNCT00381251Phase 1
• Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving LetrozoleCompletedNCT00376740Phase 3
• HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.CompletedNCT00376662Phase 4
• The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid TreatmentCompletedNCT00372372Phase 4
• Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid TherapyCompletedNCT00371956Phase 4
• Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98CompletedNCT00369850Phase 3
• Effect of Soy Bread on Markers of Bone Metabolism and Cardiovascular DiseaseCompletedNCT00366860Phase 1
• A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With ForteoCompletedNCT00365924Not applicable
• Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) ProgrammeActive, not recruitingNCT00359047Not applicable
• Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal WomenCompletedNCT00358176Phase 3
• Effect of Calcium and Vitamin D on Bone Loss From the HipCompletedNCT00357643Phase 3
• Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical TrialCompletedNCT00354302Phase 3
• Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal WomenCompletedNCT00353080Phase 3
• Calcium and Vitamin D Malnutrition in Elderly WomenCompletedNCT00352170Phase 3
• Risedronate in Postmenopausal Women With Low Bone DensityCompletedNCT00351091Phase 2
• The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKLWithdrawnNCT00347737Not applicable
• Magnesium Supplementation to Prevent Bone LossCompletedNCT00346658Phase 1
• The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.Status unknownNCT00346190Phase 3
• Risedronate in Osteopenic Postmenopausal WomenCompletedNCT00345644Phase 3
• Osteoporosis in Children With ALLCompletedNCT00330538
• Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal WomenCompletedNCT00330096Phase 3
• After Discharge Management of Low Income Frail ElderlyCompletedNCT00328848Not applicable
• Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly AlendronateCompletedNCT00327990Phase 4
• Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCISWithdrawnNCT00324714Phase 3
• Markers of Bone Turnover in Saliva and How This Compares to Urine and BloodCompletedNCT00323336
• Regaining Bladder Control in Postmenopausal Women With OsteoporosisCompletedNCT00323245Not applicable
• The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia NervosaCompletedNCT00320567Phase 2
• Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and AllergyCompletedNCT00316667
• 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal WomenCompletedNCT00310531Phase 3
• The Prevalence of Osteoporosis in Hemodialysis PatientsCompletedNCT00308828
• Prostate Adenocarcinoma TransCutaneous HormonesStatus unknownNCT00303784Phase 3
• Use of Bisphosphonates in the Treatment of Osteopathy After Liver TransplantationStatus unknownNCT00302484Not applicable
• Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal WomenCompletedNCT00301353Not applicable
• Effects of Tibolone Treatment on the EndometriumCompletedNCT00294463Phase 4

← Osteoporosis overview